Skip to main content
. 2017 Jan 3;8(8):12764–12774. doi: 10.18632/oncotarget.14463

Figure 1. HHT and ibrutinib inhibit the growth of AML cell lines.

Figure 1

The cell viability induced by HHT and ibrutinib in AML cell lines at 24 h (A). The rate of cell viability induced by HHT, ibrutinib and HHT+ibrutinib in MV4-11cells (B), MOLM-13 cells (C), HL-60 cells (D) and Kasumi-1 cells (E) was measured by a MTT assay. The CI at the ED50, ED75 and ED90 were presented (F). The data are presented as mean inhibition rates ±SD from at least three independent experiments.